Tahania joined the Centre for Cancer Screening, Prevention and Early Diagnosis as a post-doctoral research fellow in January 2024. At present, her research endeavours primarily revolve around a breast cancer project, wherein she is investigating the efficacy of serum estradiol and other hormonal markers in identifying women who are most likely to respond to preventive treatment for breast cancer. Additionally, her focus extends to understanding the risk factors associated with Oesophageal cancers and elucidating variations across different countries. She completed a PhD in "Multimorbidity in cancer survivors in the UK", focusing on variation by ethnicity and socio-economic condition.

Line Hjøllund Pedersen works at the Danish Cancer Society. She holds a PhD in social inequality and childhood cancer. In recent years, she has worked on risk-based breast cancer screening. With a diverse academic background and expertise in various methodologies, she has significantly contributed to the PRSONAL study since its inception. Line has collaborated closely with women from the target group and skilled researchers both nationally and internationally. She is a co-author of several scientific publications and has additional publications on the PRSONAL study underway.

Adoma Manful is a 4th year candidate in the Vanderbilt University Epidemiology Doctoral Program. She is passionate about mitigating health disparities and improving health outcomes by addressing socio-contextual determinants of health. Her primary research interests involve using epidemiologic methods to analyse large administrative and research databases to inform policy for high-quality, equitable healthcare. She spent several years working in health services research and data analysis and her current research focuses on analytic methods to address racial disparities in lung cancer screening eligibility.

Andrea Gini is a statistician (MSc, University of Padua) with a PhD in Public Health (Erasmus University Medical Centre in Rotterdam). During his PhD, he performed research with the MISCAN-Colon model on the impacts of colorectal cancer screening on quite different populations (including childhood cancer survivors and individuals with Cystic Fibrosis). After defending his PhD thesis, he started working at IARC/WHO in Lyon. There, he collaborates in several international studies and projects (CRICCS, METHIS, RISCC, and HPV Faster Implement) structuring mathematical simulation models to assess the impact of several cancer preventive policies at population level.

Brenda van Stigt holds a Bachelor's degree in Health and Life Sciences and a Master's degree in Nutrition and Health. She is currently a second-year PhD candidate at the Erasmus Medical Center in Rotterdam, specializing in cancer screening. Her PhD focuses on the monitoring and evaluation of the Dutch population-based cancer screening programs.

Pernille Thordal Larsen is a postdoctoral researcher and epidemiologist at Sygehus Lillebaelt in Denmark, working in the Research Unit for Screening and Epidemiology. She holds an MSc in Health Science and recently defended her PhD at Aarhus University and UNICCA (University Clinic for Cancer Screening). Her PhD focused on colorectal cancer and advanced adenoma detection following positive FIT screenings and subsequent colonoscopies without malignant findings. Her research is primarily register-based, aiming to optimize the balance between the benefits and harms of cancer screening.